Benitec Biopharma Inc. SEC filings BNTC

Benitec Biopharma Inc. has 334 filings in SEC EDGAR's recent list, going back to Apr 15, 2020. Its latest annual report, Form 10-K, was filed on Sep 14, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 14, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (regulation fd disclosure). The company's fiscal year ends on June 30.

Benitec Biopharma Inc. SEC filings
Form Description Filed Period
8-K Current report
Regulation FD disclosure
Oct 28, 2026 Oct 28, 2026
DEFA14A Additional proxy material Oct 20, 2026 —
DEF 14A Proxy statement Oct 20, 2026 Oct 20, 2026
8-K Current report
Regulation FD disclosure
Oct 5, 2026 Oct 5, 2026
8-K Current report
Auditor change
Sep 30, 2026 Sep 29, 2026
8-K Current report
Auditor change
Sep 24, 2026 Sep 18, 2026
EFFECT Filing Sep 21, 2026 —
S-3 Shelf registration Sep 14, 2026 —
10-K Annual report Sep 14, 2026 Jun 30, 2026
8-K Current report
Results of operations
Sep 14, 2026 Sep 14, 2026
4 Insider transaction Jun 30, 2026 Jun 29, 2026
8-K Current report
Officer or director change
May 29, 2026 May 22, 2026
4 Insider transaction May 28, 2026 May 26, 2026
3 Initial insider ownership May 28, 2026 May 22, 2026
10-Q Quarterly report May 14, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 14, 2026 May 14, 2026
UPLOAD Letter from the SEC Apr 3, 2026 —
CORRESP Letter to the SEC Mar 20, 2026 —
10-K/A Amended annual report Mar 20, 2026 Jun 30, 2025
UPLOAD Letter from the SEC Feb 24, 2026 —
8-K Current report
Results of operations
Feb 12, 2026 Feb 12, 2026
10-Q Quarterly report Feb 12, 2026 Dec 31, 2025
424B3 Prospectus Feb 11, 2026 —
EFFECT Filing Feb 10, 2026 —
CORRESP Letter to the SEC Feb 6, 2026 —
UPLOAD Letter from the SEC Feb 6, 2026 —
S-3 Shelf registration Jan 30, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 29, 2026 —
4 Insider transaction Jan 26, 2026 Jan 22, 2026
4 Insider transaction Dec 29, 2025 Dec 23, 2025
4 Insider transaction Dec 22, 2025 Dec 18, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Dec 8, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Dec 3, 2025 —
4 Insider transaction Dec 3, 2025 Dec 1, 2025
4 Insider transaction Dec 3, 2025 Dec 1, 2025
4 Insider transaction Dec 3, 2025 Dec 1, 2025
4 Insider transaction Dec 3, 2025 Dec 1, 2025
4 Insider transaction Dec 3, 2025 Dec 1, 2025
8-K Current report
Shareholder vote results
Dec 2, 2025 Dec 1, 2025
4 Insider transaction Nov 20, 2025 Nov 18, 2025
4 Insider transaction Nov 20, 2025 Nov 18, 2025
4 Insider transaction Nov 20, 2025 Nov 18, 2025
8-K Current report
Results of operations
Nov 14, 2025 Nov 14, 2025
10-Q Quarterly report Nov 14, 2025 Sep 30, 2025
DEFA14A Additional proxy material Nov 12, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Nov 10, 2025 —
4 Insider transaction Nov 10, 2025 Nov 7, 2025
4 Insider transaction Nov 7, 2025 Nov 5, 2025
3 Initial insider ownership Nov 7, 2025 Nov 3, 2025
8-K Current report
Material agreement, Other events
Nov 7, 2025 Nov 5, 2025
424B5 Prospectus supplement Nov 7, 2025 —
424B5 Prospectus supplement Nov 5, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 4, 2025 —
8-K Current report
Officer or director change, Regulation FD disclosure, Other events
Nov 3, 2025 Nov 2, 2025
DEFA14A Additional proxy material Oct 14, 2025 —
DEF 14A Proxy statement Oct 14, 2025 Dec 1, 2025
EFFECT Filing Sep 29, 2025 —
CORRESP Letter to the SEC Sep 26, 2025 —
UPLOAD Letter from the SEC Sep 25, 2025 —
S-3 Shelf registration Sep 22, 2025 —
8-K Current report
Results of operations
Sep 22, 2025 Sep 22, 2025
10-K Annual report Sep 22, 2025 Jun 30, 2025
8-K Current report
Restatement
Sep 12, 2025 Sep 10, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
8-K Current report
Regulation FD disclosure
Jul 9, 2025 Jul 9, 2025
EFFECT Filing Jun 2, 2025 —
424B3 Prospectus Jun 2, 2025 —
CORRESP Letter to the SEC May 29, 2025 —
UPLOAD Letter from the SEC May 29, 2025 —
S-3 Shelf registration May 23, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 14, 2025 —
8-K Current report
Results of operations
May 14, 2025 May 14, 2025
10-Q Quarterly report May 14, 2025 Mar 31, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 9, 2025 —
4 Insider transaction Apr 2, 2025 Mar 31, 2025
8-K Current report
Other events
Mar 28, 2025 Mar 26, 2025
4 Insider transaction Mar 28, 2025 Mar 26, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Mar 28, 2025 —
8-K Current report
Material agreement
Mar 27, 2025 Mar 26, 2025
424B5 Prospectus supplement Mar 26, 2025 —
8-K Current report
Material agreement, Other events
Mar 26, 2025 Mar 25, 2025
8-K Current report
Other events
Mar 20, 2025 Mar 20, 2025
8-K Current report
Regulation FD disclosure
Mar 19, 2025 Mar 19, 2025
4 Insider transaction Mar 13, 2025 Mar 12, 2025
4 Insider transaction Mar 3, 2025 Feb 27, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
8-K Current report
Results of operations
Feb 14, 2025 Feb 14, 2025
10-Q Quarterly report Feb 14, 2025 Dec 31, 2024
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 27, 2025 —
3 Initial insider ownership Jan 3, 2025 Jan 1, 2025
8-K/A Amended current report
Officer or director change
Dec 31, 2024 Dec 27, 2024
4 Insider transaction Dec 26, 2024 Dec 23, 2024
8-K Current report
Officer or director change
Dec 13, 2024 Dec 9, 2024
4 Insider transaction Dec 11, 2024 Dec 9, 2024
4 Insider transaction Dec 11, 2024 Dec 9, 2024
4 Insider transaction Dec 11, 2024 Dec 9, 2024
4 Insider transaction Dec 11, 2024 Dec 9, 2024
4 Insider transaction Dec 11, 2024 Dec 9, 2024
4 Insider transaction Dec 11, 2024 Dec 9, 2024
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Dec 10, 2024 Dec 9, 2024
8-K Current report
Shareholder vote results
Dec 6, 2024 Dec 4, 2024
SC 13G/A Amended ownership over 5% (passive) Dec 6, 2024 —
4 Insider transaction Dec 5, 2024 Dec 3, 2024
4 Insider transaction Nov 21, 2024 Nov 19, 2024
SC 13D/A Amended ownership over 5% (active) Nov 18, 2024 —
SCHEDULE 13G Ownership over 5% (passive) Nov 14, 2024 —
8-K Current report
Results of operations
Nov 14, 2024 Nov 14, 2024
DEFA14A Additional proxy material Nov 14, 2024 —
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
8-K Current report
Officer or director change
Nov 14, 2024 Nov 7, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 13, 2024 —
EFFECT Filing Nov 12, 2024 —
CORRESP Letter to the SEC Nov 12, 2024 —
UPLOAD Letter from the SEC Nov 8, 2024 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 7, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 6, 2024 —
S-3 Shelf registration Nov 1, 2024 —
SC 13G/A Amended ownership over 5% (passive) Oct 25, 2024 —
DEF 14A Proxy statement Oct 22, 2024 Dec 4, 2024
DEFA14A Additional proxy material Oct 22, 2024 —
8-K Current report
Regulation FD disclosure
Oct 15, 2024 Oct 12, 2024
424B5 Prospectus supplement Oct 15, 2024 —
424B5 Prospectus supplement Oct 11, 2024 —
PRE 14A Preliminary proxy statement Oct 11, 2024 Oct 11, 2024
8-K Current report
Material agreement
Oct 11, 2024 Oct 11, 2024
8-K Current report
Other events
Oct 8, 2024 Oct 8, 2024
S-8 Employee stock plan registration Oct 1, 2024 —
SC 13D/A Amended ownership over 5% (active) Sep 30, 2024 —
4 Insider transaction Sep 30, 2024 Sep 26, 2024
8-K Current report
Results of operations
Sep 26, 2024 Sep 26, 2024
10-K Annual report Sep 26, 2024 Jun 30, 2024
8-K Current report
Officer or director change, Shareholder vote results
Sep 5, 2024 Aug 29, 2024
DEF 14A Proxy statement Jul 29, 2024 Aug 29, 2024
PRE 14A Preliminary proxy statement Jul 19, 2024 Jul 19, 2024
8-K Current report
Regulation FD disclosure
Jul 15, 2024 Jul 15, 2024
3 Initial insider ownership Jul 8, 2024 Jun 26, 2024
8-K Current report
Officer or director change
Jul 1, 2024 Jun 26, 2024
424B3 Prospectus May 29, 2024 —
EFFECT Filing May 28, 2024 —
CORRESP Letter to the SEC May 23, 2024 —
UPLOAD Letter from the SEC May 22, 2024 —
S-1 Registration statement May 16, 2024 —
8-K Current report
Results of operations
May 13, 2024 May 13, 2024
10-Q Quarterly report May 13, 2024 Mar 31, 2024
3 Initial insider ownership May 2, 2024 Apr 22, 2024
SC 13D Ownership over 5% (active) Apr 29, 2024 —
SC 13G Ownership over 5% (passive) Apr 29, 2024 —
SC 13G Ownership over 5% (passive) Apr 29, 2024 —
D Filing Apr 25, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Apr 19, 2024 Apr 17, 2024
8-K Current report
Regulation FD disclosure
Apr 18, 2024 Apr 18, 2024
SC 13G/A Amended ownership over 5% (passive) Apr 11, 2024 —
8-K Current report
Officer or director change
Mar 8, 2024 Mar 6, 2024
4 Insider transaction Mar 8, 2024 Mar 6, 2024
4 Insider transaction Mar 8, 2024 Mar 6, 2024
EFFECT Filing Mar 5, 2024 —
CORRESP Letter to the SEC Mar 1, 2024 —
UPLOAD Letter from the SEC Feb 28, 2024 —
DEL AM Filing Feb 26, 2024 —
S-3 Shelf registration Feb 23, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
8-K Current report
Results of operations
Feb 13, 2024 Feb 13, 2024
10-Q Quarterly report Feb 13, 2024 Dec 31, 2023
S-8 Employee stock plan registration Dec 26, 2023 —
SC 13G/A Amended ownership over 5% (passive) Dec 11, 2023 —
4 Insider transaction Dec 7, 2023 Dec 6, 2023
4 Insider transaction Dec 7, 2023 Dec 6, 2023
4 Insider transaction Dec 7, 2023 Dec 6, 2023
8-K Current report
Officer or director change, Shareholder vote results
Dec 7, 2023 Dec 6, 2023
8-K Current report
Regulation FD disclosure
Nov 30, 2023 Nov 30, 2023
8-K Current report
Results of operations
Nov 13, 2023 Nov 13, 2023
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
DEFA14A Additional proxy material Oct 20, 2023 —
DEF 14A Proxy statement Oct 20, 2023 Dec 6, 2023
8-K Current report
Officer or director change
Oct 16, 2023 Oct 11, 2023
8-K Current report
Other events
Sep 28, 2023 Sep 28, 2023
8-K Current report
Results of operations
Sep 21, 2023 Sep 21, 2023
10-K Annual report Sep 21, 2023 Jun 30, 2023
8-K Current report
Officer or director change
Sep 18, 2023 Sep 13, 2023
SC 13G/A Amended ownership over 5% (passive) Sep 11, 2023 —
SC 13G Ownership over 5% (passive) Aug 25, 2023 —
SC 13G Ownership over 5% (passive) Aug 21, 2023 —
SC 13G Ownership over 5% (passive) Aug 18, 2023 —
SC 13G/A Amended ownership over 5% (passive) Aug 18, 2023 —
4 Insider transaction Aug 14, 2023 Aug 11, 2023
4 Insider transaction Aug 14, 2023 Aug 11, 2023
8-K Current report
Material agreement, Other events
Aug 11, 2023 Aug 8, 2023
8-K Current report
Listing notice
Aug 10, 2023 Aug 9, 2023
424B4 Prospectus Aug 10, 2023 —
EFFECT Filing Aug 8, 2023 —
S-1/A Amended registration statement Aug 7, 2023 —
CORRESP Letter to the SEC Aug 3, 2023 —
CORRESP Letter to the SEC Aug 3, 2023 —
S-1/A Amended registration statement Aug 3, 2023 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
BNTC (Nasdaq)
Fiscal year ends
June 30
Incorporated in
DE
Headquarters
Hayward, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1808898

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.